Independent Director · Prelude Therapeutics Inc (PRLD)

Paul Scherer director compensation at Prelude Therapeutics: $81.6K

Fiscal year 2025 director compensation for Paul Scherer at Prelude Therapeutics Inc. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Paul Scherer’s full pay file as a PDF — free

More than this page: up to 10 years of Paul’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Paul Scherer and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Prelude Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Prelude Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$24,500—$57,066—$81,566

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prelude Therapeutics Inc DEF 14A filed April 29, 2026, accession 0001193125-26-191532, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Prelude Therapeutics Inc filed document, accession 0001193125-26-191532. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Prelude Therapeutics Board Governance Report

$81,566 Paul Scherer, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Prelude Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance

The rest of the Prelude Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
David P. BonitaIndependent Director$86,033
Katina DortonIndependent Director$77,564
Krishna VaddiDirector—
Martin BablerIndependent Director$78,533
Paul A. FriedmanIndependent Director$102,533
Victor SandorIndependent Director$194,528

The full Prelude Therapeutics compensation record

free company brief

This page is one director within Prelude Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order PRLD

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report